Grants
| Grant | Principal Investigator | Funding | Project ID | Project Title | Start of the Funding Period | End of the Funding Period | Semmelweis University Partners | External Partners |
|---|---|---|---|---|---|---|---|---|
| National Cardiovascular Laboratory | Béla Merkely, MD, PhD | 5 450 173 863 HUF | RRF-2.3.1-21-2022-00003 | National Cardiovascular Laboratory | 1 April 2022 | 31 May 2026 | Városmajor Heart and Vascular Surgery Clinic (Consortium Lead), Institute of Public Health, Institute of Genetics, Cell and Immunobiology, Department of Internal Medicine and Oncology | Univesity of Szeged, Pharmahungary 2000 Kft., Intersynk Kft., 3D Histech Kft. |
| Establishing and developing competence centres | Béla Merkely, MD, PhD | 3 886 027 141 HUF | 2022-1.1.1-KK-2022-00005 | The Future Health Competence Centre at Semmelweis University | 1 April 2023 | 31 March 2028 | Femtonics Kft., MEDRES Kft., Oncompass Medicine Hungary Kft., Richter Gedeon Nyrt. | |
| HU-rizon Programme | Péter Ferdinandy, MD, PhD, MBA | 400 000 000 HUF | 2024-1.2.3-HU-RIZONT-2024-00026 | Development of an artificial intelligence–based drug discovery platform: application of microRNA therapy in cardiometabolic and oncological diseases | 1 March 2025 | 29 February 2028 | ||
| Semmelweis University Internal Momentum Programme 2024 | Péter Ferdinandy, MD, PhD, MBA | 100 000 000 | SE11594386 | Development of microRNA therapies for cardiometabolic and oncological diseases | 15 July 2024 | 14 July 2025 | ||
| Thematic Excellence Programme 2021 – Health Subprogramme | Péter Ferdinandy, MD, PhD, MBA | 332 500 000 HUF | TKP2021-EGA-23 | Translational research and innovation in the diagnosis and therapy of ischemic heart disease and its comorbidities | 1 August 2021 | December 31 2025 | Városmajor Heart and Vascular Surgery Clinic, Institute of Genetics, Cell and Immunobiology, Department of Oral Biology, Center for Translational Medicine, Institute of Biophysics and Radiation Biology | |
| Support for Bilateral Scientific and Technological Cooperation (2024-1.2.5-TÉT) | Anikó Görbe, MD, PhD | 3 000 000 HUF | 2024-1.2.5-TÉT-2024-00059 | Development of novel microRNA-based therapies for the protection of cardiac function | 1 July 2025 | 30 June 2027 | Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia | |
| K_21 OTKA | Anikó Görbe, MD, PhD | 45 983 000 HUF | K 139237 | Investigation of hidden cardiotoxicity and cardioprotection using translational cell culture models | 1 September 2021 | 30 June 2026 | ||
| Momentum Programme | Zoltán Varga, MD, PhD | 180 002 000 HUF | LP-2021-14 | Investigation of the molecular mechanisms of cardiological and onco-cardiological diseases, as well as their therapeutic and diagnostic applications | 01 December 2021 | 30 November 2026 | ||
| K_21 OTKA | Zoltán Giricz, PharmD, PhD | 46 960 000 HUF | K 139105 | Impact of metabolic diseases on extracellular vesicle–based signaling in the cardiovascular system | 1 September 2021 | 31 July 2026 | ||
| Support for International Professional and Scientific Cooperation (2024-1.2.9-NETWORKING) | Zoltán Giricz, PharmD, PhD | 3 000 000 HUF | 2024-1.2.9-NETWORKING-2024-00016 | Participation in the leadership of the European Society of Cardiology Working Group on Cellular Biology with the aim of developing position papers | 1 August 2025 | 31 July 2026 | ||
| National Research Excellence Programme 2025 - ADVANCED | Zoltán Giricz, PharmD, PhD | 147 000 000 HUF | ADVANCED 15291 | Investigation of the therapeutic potential of stem cell–derived extracellular vesicles in cancer therapy–induced cardiac injury | 1 January 2026 | 31 December 2029 | ||
| National Research Excellence Programme 2025 - STARTING | András Makkos, MD, PhD | 97 200 000 HUF | STARTING_152265 | Preclinical development of cardioprotective microRNA molecules (ProtectomiRs) | 1 January 2026 | 31 December 2029 | ||
| National Research Excellence Program 2025 - STARTING | Zsófia Gulyás-Onódi, MD, PhD | 125 000 000 HUF | STARTING 152247 | Investigation of immuno-inflammatory processes and their pharmacological relevance in heart diseases and their comorbidities | 1January 2026 | 31 December 2029 | ||
| Bolyai János Scholarship 2023 | Gábor Mórotz, PhD | 9 000 000 HUF | BO/00277/23/5 | Adrenal steroid hormone synthesis and endoplasmic reticulum (ER)–mitochondrial signaling in post-infarction heart failure | 1 September 2023 | 31 August 2026 | ||
| OTKA FK | Gábor Mórotz, PhD | 44 000 000 HUF | FK_146163 | Endothelial cells and ER–mitochondrial signaling in myocardial infarction–associated microvascular obstruction | 1 January 2024 | 31 December 2027 | ||
| Richter Talentum Excellence PhD Scholarship | Richárd Rácz | 6 400 000 HUF | Richter Talentum Excellence PhD Scholarship | 1 September 2024 | 31 August 2026 | |||
| MTA INKP | Zsófia Gulyás-Onódi, MD, PhD | 700 000 HUF | INKP_2026-5 | World Congress of Basic and Clinical Pharmacology 2026. részvétel támogatása | 1 January 2026 | 15 December 2026 |
Research projects funded by grants
